232 related articles for article (PubMed ID: 25155494)
1. Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab.
Marasà M; Cravedi P; Ruggiero B; Ruggenenti P
BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25155494
[TBL] [Abstract][Full Text] [Related]
2. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
Kisner T; Burst V; Teschner S; Benzing T; Kurschat CE
Nephron Clin Pract; 2012; 120(2):c79-85. PubMed ID: 22286071
[TBL] [Abstract][Full Text] [Related]
3. Rituximab for refractory focal segmental glomerulosclerosis.
Nakayama M; Kamei K; Nozu K; Matsuoka K; Nakagawa A; Sako M; Iijima K
Pediatr Nephrol; 2008 Mar; 23(3):481-5. PubMed ID: 17973121
[TBL] [Abstract][Full Text] [Related]
4. Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab.
Suri M; Tran K; Sharma AP; Filler G; Grimmer J
Int Urol Nephrol; 2008; 40(3):807-10. PubMed ID: 18491215
[TBL] [Abstract][Full Text] [Related]
5. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
Kolonko A; Piecha G; Więcek A
Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
[TBL] [Abstract][Full Text] [Related]
6. Rituximab treatment for adult patients with focal segmental glomerulosclerosis.
Ochi A; Takei T; Nakayama K; Iwasaki C; Kamei D; Tsuruta Y; Shimizu A; Shiohira S; Moriyama T; Itabashi M; Mochizuki T; Uchida K; Tsuchiya K; Hattori M; Nitta K
Intern Med; 2012; 51(7):759-62. PubMed ID: 22466834
[TBL] [Abstract][Full Text] [Related]
7. Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis.
Fernandez-Fresnedo G; Segarra A; González E; Alexandru S; Delgado R; Ramos N; Egido J; Praga M;
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1317-23. PubMed ID: 19578004
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.
Basu B; Mahapatra TK; Mondal N
Pediatrics; 2015 Jul; 136(1):e132-9. PubMed ID: 26101364
[TBL] [Abstract][Full Text] [Related]
9. High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Radin M; Barreca A; Fenoglio R; Baldovino S; Menegatti E
Am J Nephrol; 2017; 46(2):108-113. PubMed ID: 28700988
[TBL] [Abstract][Full Text] [Related]
10. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
Rodríguez-Ferrero M; Ampuero J; Anaya F
Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
[TBL] [Abstract][Full Text] [Related]
11. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis.
Ino A; Kaori S; Takei T; Nitta K
CEN Case Rep; 2020 Aug; 9(3):195-199. PubMed ID: 31997159
[TBL] [Abstract][Full Text] [Related]
12. Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis.
Wee Leng G; Mustafar R; Kamaruzaman L; Mohd R; Cader RA; Wei Yen K; Kiew Bing P
Acta Med Indones; 2018 Jul; 50(3):237-243. PubMed ID: 30333274
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.
Cho JH; Lee JH; Park GY; Lim JH; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Ren Fail; 2014 May; 36(4):623-6. PubMed ID: 24502587
[TBL] [Abstract][Full Text] [Related]
14. Rituximab in treatment of idiopathic glomerulopathy.
El-Reshaid K; Sallam HT; Hakim AA; Al-Attiyah R
Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):973-8. PubMed ID: 22982909
[TBL] [Abstract][Full Text] [Related]
15. Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases.
Kronbichler A; König P; Busch M; Wolf G; Mayer G; Rudnicki M
Wien Klin Wochenschr; 2013 Jun; 125(11-12):328-33. PubMed ID: 23624956
[TBL] [Abstract][Full Text] [Related]
16. Persistent CD-19 depletion by rituximab is cost-effective in maintaining remission in calcineurin-inhibitor dependent podocytopathy.
Ramachandran R; Bharati J; Rao I; Kashif AW; Nada R; Minz R; Gupta KL; Kohli HS
Nephrology (Carlton); 2019 Dec; 24(12):1241-1247. PubMed ID: 30586217
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study.
Lan L; Lin Y; Yu B; Wang Y; Pan H; Wang H; Lou X; Lang X; Zhang Q; Jin L; Yang Y; Xiao L; Chen J; Han F
Am J Nephrol; 2024; 55(1):25-36. PubMed ID: 37963441
[TBL] [Abstract][Full Text] [Related]
18. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.
Hansrivijit P; Cheungpasitporn W; Thongprayoon C; Ghahramani N
BMC Nephrol; 2020 Apr; 21(1):134. PubMed ID: 32293308
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of recurrent focal segmental glomerulosclerosis after renal transplantation by lymphocytapheresis and rituximab.
Shimizu M; Kitagawa K; Nishio S; Yokoyama T; Furuichi K; Ohta K; Wada T; Yachie A
Transpl Int; 2010 Sep; 23(9):e53-5. PubMed ID: 20536913
[No Abstract] [Full Text] [Related]
20. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports.
Kamar N; Faguer S; Esposito L; Guitard J; Nogier MB; Durand D; Rostaing L
Clin Nephrol; 2007 Apr; 67(4):250-4. PubMed ID: 17474562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
